ISECAROSMAB
UNII 3DQY5VE61P

Substance Identification & Data

This profile provides standardized clinical and technical data for Isecarosmab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3DQY5VE61P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2254082-79-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3DQY5VE61P
CAS Registry Number
2254082-79-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ISECAROSMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C175097
National Cancer Institute reference terminology for clinical and research data.
INN ID
11315
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Isecarosmab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ISECAROSMAB

Common Names & Synonyms

IMMUNOGLOBULIN G, ANTI-(HUMAN METALLOPROTEINASE ADAMTS-5) (HUMAN-LAMA GLAMA MONOCLONAL 2F3 .GAMMA.-CHAIN V-D-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)7 FUSION PROTEIN WITH IMMUNOGLOBULIN G (C-TERMINAL-ALANINE) ANTI-(HUMAN SERUM ALBUMIN) (HUMAN-LAMA MONOCLONAL ALB11 .GAMMA.-CHAIN V-D-J REGION)
IMMUNOGLOBULIN SINGLE CHAIN VH-VH', ANTI-(HOMO SAPIENS ADAMTSL5 (ADAMTS LIKE 5, THSD6, THROMBOSPONDIN TYPE I DOMAIN 6)) AND ANTI-(HOMO SAPIENS ALB (ALBUMIN, HUMAN SERUM ALBUMIN, HSA)), LAMA GLAMA AND HUMANIZED MONOCLONAL ANTIBODY, BISPECIFIC BIVALENTSC VH-VH'(1-275) (LAMA GLAMA VH ANTI-ADAMTSL5 (LAMA GLAMA IGHV3S1*01 (81.4%)-(IGHD)-IGHJ2*01 (100%)/HOMO SAPIENS IGHV3-23*04 (80.2%)-(IGHD)-IGHJ1*01 (100%) (8.8.17) (1-124))-35-MER (GGGGS)7 LINKER (125-159)-HUMANIZED VH ANTI-ALB (HOMO SAPIENS IGHV3-23*04 (87.5%)-(IGHD)-IGHJ1*01 (100%) (8.8.8) (160-275), PRODUCED IN PICHIA PASTORIS YEAST, NONGLYCOSYLATED
ISECAROSMAB [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus